Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arm Holdings plc (ARM) vs Neurocrine Biosciences Inc (NBIX) Price & Performance

Arm Holdings plcTrade
Neurocrine Biosciences IncTrade

Price performance (Past 24H)

Key statistics

Arm Holdings plc vs Neurocrine Biosciences Inc — how do they compare? Arm Holdings plc trades at $274.3 (market cap $287.22B), while Neurocrine Biosciences Inc trades at $152.18 (market cap $16.46B). The key difference: Arm Holdings plc is far larger — about 17.4× Neurocrine Biosciences Inc's market cap. Which is the better fit depends on your goals.

ARMNBIX
Market Cap
$287.22B$16.46B
Sector
TechnologyHealth
52-Week High
$439.46$185.50
52-Week Low
$104.55$123.10
Enterprise Value
$283.79B$16.48B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Arm Holdings plc

Arm Holdings designs the architecture for high-performance, energy-efficient processors used in nearly all smartphones and millions of other devices. Its intellectual property powers global computing from mobile to AI.

Read more on ARM

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX